FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Jiangsu, China

Biotech startups in Jiangsu, China

Updated 16 Nov 2026

Reset
Biotech startups in Jiangsu, China
One-time CSV
  • 225 funded companies, 142 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~jiangsu-china.csv225 rows × 18 columns
CompanyCityLast roundAmountDate
Weikaier Pharmaceutical TechnologyNanjingSeries C$29.6M2026-06-02
D3 BioWuxi ShiSeries B$108.0M2025-12-09
HemaCellSuzhouSeries B$14.8M2026-06-02
iCamumoSuzhouSeries A$14.4M2026-03-09
Yuce BiotechnologySuzhouSeries B$7.4M2026-08-31
IMPACT TherapeuticsNanjingSeries D$34.6M2024-11-15
CureGeneticsSuzhouSeries B$9.0M2024-03-28
PRCXI BiotechnologySuzhouSeries A$14.0M2025-12-31

8 rows of the CSV in 5 of its 18 columns.

225
Startups
$4.0B
Total raised
47
Funded in the last 12 months
$661.5M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

15 of 225
15 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Yuce Biotechnology Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. Biotech Suzhou Series B $7.4M 2026-08-31 $22.4M Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 101 to 250 2019
Weikaier Pharmaceutical Technology Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. Biotech Nanjing Series C $29.6M 2026-06-02 $120.4M SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 501 to 1,000 2010
HemaCell HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. Biotech Suzhou Series B $14.8M 2026-06-02 $62.0M Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation 1 to 10 2021
iCamumo iCamumo develops off-the-shelf, general-purpose cell therapies using iPSCs. Biotech Suzhou Series A $14.4M 2026-03-09 $75.2M Delian Capital, West Lake Science and Technology Direct Investment Fund, Zhiyi Investment 51 to 100 2021
Micro-Ray Technology Micro-Ray Technology supplies X-ray tubes and component solutions for medical imaging equipment such as CT machines. Biotech Suzhou Seed $14.4M 2026-01-23 $14.4M Suzhou Xiangcheng Financial Holding Group 11 to 50 2021
PRCXI Biotechnology PRCXI Biotechnology provides analytical instruments, bioinformatics, and automation solutions for life sciences. Biotech Suzhou Series A $14.0M 2025-12-31 $55.0M Qiming Venture Partners, SAIF Partners 101 to 250 2014
D3 Bio D3 Bio develops and registers medicines as a biotechnology company. Biotech Wuxi Shi Series B $108.0M 2025-12-09 $370.0M Matrix Partners China, Boyu Capital, Medicxi 1 to 10 2020
Kunshi Biotechnology Kunshi Biotechnology develops drugs with an emphasis on solid tumor cells. Biotech Suzhou Series A $7.0M 2025-11-20 $7.0M Deshi Capital 51 to 100 2021
IMPACT Therapeutics IMPACT Therapeutics develops similar drugs to treat cancer. Biotech Nanjing Series D $34.6M 2024-11-15 BioVenture, Lilly Asia Ventures, Decheng Capital +2 51 to 100 2009
Wimi bio Wimi Bio researches and develops gene editing and biological breeding technologies as a high-tech enterprise. Biotech Nanjing Series A $14.1M 2024-09-19 HosenCare Brothers 51 to 100 2017
Yidao Biotechnology Yidao Biotechnology researches and develops vaccines and biomedical products. Biotech Suzhou Series D $25.2M 2024-05-09 Qiming Venture Partners, Northern Light Venture Capital 2017
CureGenetics CureGenetics develops medicines and molecular diagnostics for cancers and genetic diseases. Biotech Suzhou Series B $9.0M 2024-03-28 Qiming Venture Partners, Oriza Holdings, Qingsong Fund +1 51 to 100 2016
Atom Bioscience & Pharmaceutical Atom Bioscience is a clinical-stage biotechnology company. Biotech Suzhou Series D $82.1M 2023-10-16 Fortune Venture Capital, Oriza Holdings, Kaitai Capital +1 11 to 50 2012
Zenshine Pharma Zenshine Pharma develops small molecule drugs for cancer and autoimmune diseases. Biotech Nanjing Series C $13.7M 2023-10-13 $28.7M Matrix Partners China, Cybernaut Venture Capital, Kunlun Capital +2 11 to 50 2018
Onechip Bioelectronics Onechip Bioelectronics develops biosensor chips and nanomaterials. Biotech Zhangjiagang Series B $13.7M 2023-09-28 Matrix Partners China, Qiming Venture Partners, Xiamen C&D Emerging Industry Equity Investment +1 11 to 50 2014

Table 1. Biotech startups in Jiangsu, China: the 15 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 225.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 D3 Bio D3 Bio develops and registers medicines as a biotechnology company. Biotech Wuxi Shi Series B $108.0M 2025-12-09 $370.0M Matrix Partners China, Boyu Capital, Medicxi 1 to 10 2020
2 Weikaier Pharmaceutical Technology Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. Biotech Nanjing Series C $29.6M 2026-06-02 $120.4M SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 501 to 1,000 2010
3 HemaCell HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. Biotech Suzhou Series B $14.8M 2026-06-02 $62.0M Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation 1 to 10 2021
4 iCamumo iCamumo develops off-the-shelf, general-purpose cell therapies using iPSCs. Biotech Suzhou Series A $14.4M 2026-03-09 $75.2M Delian Capital, West Lake Science and Technology Direct Investment Fund, Zhiyi Investment 51 to 100 2021
5 Micro-Ray Technology Micro-Ray Technology supplies X-ray tubes and component solutions for medical imaging equipment such as CT machines. Biotech Suzhou Seed $14.4M 2026-01-23 $14.4M Suzhou Xiangcheng Financial Holding Group 11 to 50 2021
6 PRCXI Biotechnology PRCXI Biotechnology provides analytical instruments, bioinformatics, and automation solutions for life sciences. Biotech Suzhou Series A $14.0M 2025-12-31 $55.0M Qiming Venture Partners, SAIF Partners 101 to 250 2014
7 Yuce Biotechnology Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. Biotech Suzhou Series B $7.4M 2026-08-31 $22.4M Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 101 to 250 2019
8 Kunshi Biotechnology Kunshi Biotechnology develops drugs with an emphasis on solid tumor cells. Biotech Suzhou Series A $7.0M 2025-11-20 $7.0M Deshi Capital 51 to 100 2021

Table 2. Biotech startups in Jiangsu, China: the 8 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Qiming Venture Partners Venture capital firm Shanghai, China 4 2% 1 PRCXI Biotechnology
2 Matrix Partners China Venture capital firm Beijing, China 3 1% 1 D3 Bio
3 Oriza Holdings Venture capital firm Suzhou, China 3 1%
4 China Life Private Equity Investment Private equity firm Beijing, China 2 1% 1 Weikaier Pharmaceutical Technology
5 CDH Investments Private equity firm Kowloon City, Hong Kong 2 1% 1 HemaCell
6 Northern Light Venture Capital Venture capital firm Beijing, China 2 1% 1 HemaCell
7 Delian Capital Venture capital firm Beijing, China 2 1% 1 iCamumo
8 Zhengxuan Investment Venture capital firm Shenzhen, China 2 1% 1 Yuce Biotechnology
9 BioVenture Venture capital firm Suzhou, China 2 1%
10 EFung Capital Private equity firm Shenzhen, China 2 1%
11 Kaitai Capital Venture capital firm Hangzhou, China 2 1%
12 SDIC Venture Capital Venture capital firm Xicheng, China 1 0% 1 Weikaier Pharmaceutical Technology
13 Nanjing Innovation Capital Group Venture capital firm Nanjing, China 1 0% 1 Weikaier Pharmaceutical Technology
14 Dyee Capital Private equity firm Xiamen, China 1 0% 1 Weikaier Pharmaceutical Technology
15 Boyu Capital Private equity firm Beijing, China 1 0% 1 D3 Bio

Table 3. Biotech startups in Jiangsu, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 195 87% $3.7B
Hardware 4 2%
Software 3 1% $100.0M
Artificial intelligence 2 1%

Table 4. Biotech startups in Jiangsu, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Seed 60 27% $6.0M
Series A 79 35% $13.7M
Series B 46 20% $28.7M
Series C 29 13% $30.0M
Series D+ 11 5% $34.6M

Table 5. Biotech startups in Jiangsu, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Suzhou 109 48%
Nanjing 70 31%
Wuxi Shi 9 4%
Taizhou 7 3%
Nantong 6 3%
Changsha 6 3%
Jiangyin 3 1%
Zhangjiagang 3 1%
Jiangning 2 1%
Yixing 1 0%
Taicang 1 0%
Lianyungang 1 0%

Table 6. Biotech startups in Jiangsu, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 5 11% $30.0M
September 2026 1 2%
August 2026 4 9% $81.9M
July 2026 2 4% $29.5M
June 2026 2 4% $44.3M
May 2026 6 13% $119.4M
April 2026 1 2% $29.3M
March 2026 4 9% $14.4M
February 2026 2 4% $50.6M
January 2026 9 19% $65.5M
December 2025 7 15% $175.3M
November 2025 4 9% $21.1M

Table 7. Biotech startups in Jiangsu, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 36 16% $465.1M
2025 36 16% $365.8M
2024 33 15% $280.0M
2023 38 17% $474.4M
2022 25 11% $594.5M
2021 17 8% $1.0B

Table 8. Biotech startups in Jiangsu, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 17 8%
2020 to 2022 58 26%
2015 to 2019 85 39%
2010 to 2014 43 20%
Before 2010 17 8%

Table 9. Biotech startups in Jiangsu, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 14 8%
11 to 50 61 34%
51 to 100 45 25%
101 to 250 27 15%
251 to 500 14 8%
501 to 1,000 11 6%
1,001 to 5,000 5 3%

Table 10. Biotech startups in Jiangsu, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Jiangsu, China are on the list?
225, in the file dated 16 November 2026. 47 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 225 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Jiangsu, China: 225 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Jiangsu, China by funding stage

Other sectors in Jiangsu

Biotech startups elsewhere

Cite: FundingWatcher, 225 funded biotech companies in Jiangsu, China, 16 November 2026. https://fundingwatcher.com/startups/biotech/jiangsu-china/